Lind Kevin Robert bought AVTX
June 2, 2026 · Form 4 insider transaction
Lind Kevin Robert bought 20,100 shares of Avalo Therapeutics, Inc. at $0.00 per share, a transaction worth N/A. The trade was recorded as grant or award and disclosed on an SEC Form 4, filed 2 days after the transaction.
Direction
Acquired (buy-side)
Shares
20,100
Price
$0.00
Total value
N/A
InsiderLind Kevin Robert
RoleOfficer, Director
SecurityStock Option (Right to Buy)
Transaction codeA: Grant or award
Transaction dateJune 2, 2026
Filing dateJune 4, 2026
Shares owned after20,100
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
The stock option vests 100% on the first anniversary of the date of grant, subject to the director's continued service on such vesting date.